Chen Yang Luke Sells Shares of 111, Inc.

Chen Yang Luke sold 44,000 shares of 111, Inc. on June 15, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 7:00 AM EDT · Updated Jun 16, 2026, 3:00 PM EDT

Key Points

Chen Yang Luke sold 44,000 shares of 111, Inc. (YI) on June 15, 2026, at an average price of $0.23 per share, totaling $10,120.
111, Inc. (YI) has a market cap of approximately $40.2 million and trades with a forward P/E of 32.64 and a beta of 0.609.
Peers like Renaissance Technologies and Citigroup also adjusted their positions in 111, Inc., with varying share changes.

On June 15, 2026, Chen Yang Luke sold 44,000 shares of 111, Inc. (NasdaqGM: YI) at an average price of $0.23 per share. The transaction was valued at $10,120. This insider sale was not part of a pre-planned trading program.

Insider Buying and Selling at 111, Inc.

Alongside Chen Yang Luke, other insiders were active around the same period. Sun Jian David sold several batches of shares, including 58,800 shares on June 15, 2026, at the same price of $0.23 per share. Prior to that, Sun Jian David also sold 111,100 shares on June 11, 2026.

Other Institutional Activity in 111, Inc.

Several institutional investors also adjusted their holdings in 111, Inc. Renaissance Technologies LLC increased its stake by 300 shares, ending with 13,014 shares valued at about $84,851. In contrast, Serenus Wealth Advisors, LLC reduced its holdings by 64 shares, leaving them with 4,320 shares worth approximately $321,334. Citigroup Inc significantly increased its position, acquiring 207 shares to hold a total of 207 shares valued at $1,341.

111, Inc. Stock Snapshot

Shares of 111, Inc. (NasdaqGM: YI) recently traded around $4.57. The company has a market capitalization of approximately $40.2 million and a forward P/E ratio of 32.64. The stock's beta is 0.609, indicating lower volatility compared to the market. Over the past year, the stock has seen a low of $2.48 and a high of $11.17. The 50-day moving average is $5.88, while the 200-day moving average is $5.40.

About 111, Inc.

111, Inc. is a healthcare company headquartered in Shanghai, China. It operates an integrated online and offline platform within the healthcare market, focusing on B2C and B2B segments. The company provides supply chain integration services, online retail pharmacy services, and offers a variety of health and wellness products. Founded in 2010, 111, Inc. serves pharmacies, pharmaceutical companies, and medical professionals across China.

Bottom Line

Chen Yang Luke's recent sale of 44,000 shares in 111, Inc. is part of a series of insider transactions in June 2026. Investors often monitor such activities for potential insights into company sentiment. It's important to remember that 13F filings and insider transactions are historical and may not reflect current positions or future intentions.